PHASE-II EVALUATION OF PHENESTERIN IN PATIENTS WITH ADVANCED OVARIAN-CANCER

被引：0
|
作者：
BLOOM, RE
POLIVOGIANIS, L
DAVIS, TE
BENNETT, JM
HORTON, J
机构：
[1] UNIV ROCHESTER,CTR CANC,ROCHESTER,NY 14642
[2] DANA FARBER CANC INST,BOSTON,MA
[3] WISCONSIN CLIN CANC CTR,MADISON,WI
[4] UNION UNIV ALBANY MED COLL,ALBANY,NY 12208
[5] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[6] AMER ONCOL HOSP,PHILADELPHIA,PA 19111
[7] UNIV HLTH SCI CHICAGO MED SCH,CHICAGO,IL 60612
[8] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,PHILADELPHIA,PA 19107
[9] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901
[10] MED COLL OHIO,TOLEDO,OH 43699
[11] NORTHWESTERN UNIV,MED CTR,CHICAGO,IL 60611
[12] UNIV PITTSBURGH,PITTSBURGH,PA 15260
[13] RUSH PRESBYTERIAN ST LUKES MED CTR,CHICAGO,IL 60612
[14] TUFTS UNIV,WALPOLE,MA
[15] NATALIE WARREN BRYANT CANC CTR,TULSA,OK
[16] YALE UNIV,SCH MED,NEW HAVEN,CT 06510
来源：
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：601 / 602
页数：2
相关论文
共 50 条
  • [21] PHASE-II TRIAL OF TRIMELAMOL IN REFRACTORY OVARIAN-CANCER
    JUDSON, IR
    CALVERT, AH
    GORE, ME
    BALMANNO, K
    GUMBRELL, LA
    PERREN, T
    WILTSHAW, E
    BRITISH JOURNAL OF CANCER, 1991, 63 (02) : 311 - 313
  • [22] PHASE-II STUDY OF FAZARABINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    MANETTA, A
    BLESSING, JA
    LOOK, KY
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02): : 156 - 157
  • [23] HIGH-DOSE PLATINUM CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - A PHASE-II STUDY
    BERTELSEN, K
    BASTHOLT, L
    GYNECOLOGIC ONCOLOGY, 1992, 44 (01) : 79 - 82
  • [24] PACLITAXEL (TAXOL(R)) FOR THE TREATMENT OF ADVANCED OVARIAN-CANCER - REVIEW OF PHASE-II TRIALS
    EINZIG, AI
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 : 3 - 6
  • [25] TENIPOSIDE (VM-26) IN PATIENTS WITH ADVANCED REFRACTORY OVARIAN-CANCER - A PHASE-II STUDY OF THE NETHERLANDS JOINT STUDY-GROUP FOR OVARIAN-CANCER
    VANDERBURG, MEL
    HUININK, WWT
    VRIESENDORP, R
    VANOOSTEROM, AT
    NEIJT, JP
    VERMORKEN, JB
    VANPUTTEN, WLJ
    KOOIMAN, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07): : 997 - 998
  • [26] RESPONSE OF PATIENTS IN PHASE-II STUDIES OF CHEMOTHERAPY IN OVARIAN-CANCER - IMPLICATIONS FOR PATIENT TREATMENT AND THE DESIGN OF PHASE-II TRIALS
    BLACKLEDGE, G
    LAWTON, F
    REDMAN, C
    KELLY, K
    BRITISH JOURNAL OF CANCER, 1989, 59 (04) : 650 - 653
  • [27] PHASE-II TRIAL OF BLEOMYCIN IN PATIENTS WITH ADVANCED OVARIAN-CANCER - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY
    VERMORKEN, JB
    ARMAND, JP
    LACAVE, AJ
    GEORGE, M
    DEOLIVEIRA, CF
    CHEIX, F
    MASKENS, AP
    ROTMENSZ, N
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (06): : 671 - 673
  • [28] ZENIPLATIN IN PATIENTS WITH ADVANCED OVARIAN-CANCER, A PHASE-II STUDY WITH A 3RD GENERATION PLATINUM COMPLEX
    WILLEMSE, PHB
    GIETEMA, JA
    MULDER, NH
    DEVRIES, EGE
    MEIJER, S
    BOUMA, J
    BIRKHOFER, M
    RASTOGI, RB
    SLEIJFER, DT
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (03) : 359 - 362
  • [29] MITOZOLAMIDE - PHASE-II STUDIES IN MELANOMA, LUNG AND OVARIAN-CANCER
    HARDING, M
    KAYE, SB
    DORWARD, A
    MACKIE, R
    SMYTHE, J
    BLACKLEDGE, G
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 216 - 216
  • [30] CYCLIC HORMONAL TREATMENT IN OVARIAN-CANCER - A PHASE-II TRIAL
    JAKOBSEN, A
    BERTELSEN, K
    SELL, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07): : 915 - 916
12345